Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Drops By 16.7%

BioNxt Solutions Inc. (OTCMKTS:BNXTFGet Free Report) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,000 shares, a drop of 16.7% from the March 31st total of 1,200 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 10,500 shares, the short-interest ratio is currently 0.1 days.

BioNxt Solutions Price Performance

Shares of OTCMKTS BNXTF opened at $0.26 on Friday. The stock’s 50-day simple moving average is $0.35 and its two-hundred day simple moving average is $0.28. BioNxt Solutions has a twelve month low of $0.11 and a twelve month high of $0.43. The firm has a market capitalization of $30.26 million, a P/E ratio of -6.54 and a beta of 0.56.

About BioNxt Solutions

(Get Free Report)

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.

Featured Articles

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.